Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease
- PMID: 37649789
- PMCID: PMC10465102
- DOI: 10.1097/TXD.0000000000001532
Transplant Center Attitudes Toward Early Liver Transplant for Alcohol-associated Liver Disease
Abstract
Background: Many centers have removed 6-mo pretransplant alcohol abstinence requirements to provide early liver transplant (ELT) for individuals with severe alcohol-associated liver disease (ALD), but the practice remains controversial. Using data collected from a nationally distributed survey, this study examines the practices and attitudes of transplant centers in the United States regarding ELT.
Methods: A 20-item survey designed to assess center practices and provider attitudes was distributed to 225 medical and surgical directors from 143 liver transplant centers via email.
Results: Surveys were completed by 28.9% (n = 65) of directors and 39% (n = 56) of transplant centers. All responding centers reported evaluating patients for ELT. Circumstances for considering ELT included <6 mo of survival without a transplant (96.4%) and inability to participate in alcohol addiction therapy pretransplant (75%). Most (66%) directors indicated their center had established criteria for listing candidates with severe ALD for ELT. Regarding important factors for ELT candidate listing, 57.1% indicated patient survival, 37.5% indicated graft survival, and 55.4% indicated having a low risk of relapse. Only 12.7% of directors affirmed the statement, "Six months of pretransplant abstinence decreases the risk of relapse."
Conclusions: More centers are providing ELT for severe ALD. Inability to participate in alcohol addiction therapy and <6 mo of survival are commonly reported circumstances for considering ELT. Continued investigation of posttransplant outcomes in patients receiving ELT is essential to establishing a national consensus for distributing this valuable resource.
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors declare no conflicts of interest.
Similar articles
-
Patient reflections, challenges, and supports related to early liver transplant for severe alcohol-associated liver disease.Liver Transpl. 2023 Jul 1;29(7):745-756. doi: 10.1097/LVT.0000000000000059. Epub 2023 Jan 3. Liver Transpl. 2023. PMID: 36728621 Free PMC article.
-
Evaluation of Early vs Standard Liver Transplant for Alcohol-Associated Liver Disease.JAMA Surg. 2021 Nov 1;156(11):1026-1034. doi: 10.1001/jamasurg.2021.3748. JAMA Surg. 2021. PMID: 34379106 Free PMC article.
-
Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder.Transplant Direct. 2025 Mar 20;11(4):e1776. doi: 10.1097/TXD.0000000000001776. eCollection 2025 Apr. Transplant Direct. 2025. PMID: 40124245 Free PMC article.
-
Liver transplantation and alcoholic liver disease: History, controversies, and considerations.World J Gastroenterol. 2018 Jul 14;24(26):2785-2805. doi: 10.3748/wjg.v24.i26.2785. World J Gastroenterol. 2018. PMID: 30018475 Free PMC article. Review.
-
Post-transplant Outcomes of Persons Receiving a Liver Graft for Alcoholic Liver Disease.Alcohol Alcohol. 2018 Mar 1;53(2):157-165. doi: 10.1093/alcalc/agx100. Alcohol Alcohol. 2018. PMID: 29293880 Review.
Cited by
-
New stories, same Stigma: Framing analysis of news articles about people with alcohol-related conditions needing liver transplants.SSM Qual Res Health. 2025 Jun;7:100567. doi: 10.1016/j.ssmqr.2025.100567. Epub 2025 May 5. SSM Qual Res Health. 2025. PMID: 40575725 Free PMC article.
References
-
- Louvet A, Naveau S, Abdelnour M, et al. . The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids. Hepatology. 2007;45:1348–1354. - PubMed
-
- Mathurin P, Lucey MR. Liver transplantation in patients with alcohol-related liver disease: current status and future directions. Lancet Gastroenterol Hepatol. 2020;5:507–514. - PubMed
-
- Thursz MR, Richardson P, Allison M, et al. ; STOPAH Trial. Prednisolone or pentoxifylline for alcoholic hepatitis. N Engl J Med. 2015;372:1619–1628. - PubMed
-
- Gustot T, Jalan R. Acute-on-chronic liver failure in patients with alcohol-related liver disease. J Hepatol. 2019;70:319–327. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources